Kokia Ehud S, Silverman Barbara G, Green Manfred, Kedem Hagai, Guindy Michal, Shemer Joshua
Maccabi Healthcare Services, 27 HaMered Street, Tel Aviv, Israel.
Vaccine. 2007 Dec 12;25(51):8557-61. doi: 10.1016/j.vaccine.2007.10.021. Epub 2007 Oct 29.
In October 2006, four deaths occurred in Israel shortly after influenza immunization, resulting in a temporary halt to the vaccination campaign. After an epidemiologic investigation, the Ministry of Health concluded that these deaths were not related to the vaccine itself and the campaign resumed; however, vaccine uptake was markedly reduced. Estimates of true background mortality in this high-risk population would aid in public education and quell unnecessary concerns regarding vaccine safety. We used data from a large HMO to estimate mortality in influenza vaccine recipients aged 55 and over during four consecutive winters (2003, 2004, 2005 and 2006). Date of immunization was ascertained from patient treatment files, vital status through Israeli National Insurance Institute data. We calculated crude death rates within 7, 14 and 30 days of influenza immunization, and used a Cox Proportional Hazards Model to estimate the risk of death within 14 days of vaccination, adjusting for age and comorbid conditions (age over 75, history of diabetes or cardiovascular disease, status as homebound patient) in 2006. The death rate among influenza vaccine recipients ranged from 0.01 to 0.02% within 7 days and 0.09-0.10% at 30 days. Influenza immunization was associated with a decreased risk of death within 14 days after adjustment for comorbidities (Hazard ratio, 0.33, 95% CI, 0.18-0.61). Our findings support the assumption that influenza vaccination is not associated with increased risk of death in the short term.
2006年10月,以色列在流感疫苗接种后不久发生了4例死亡病例,导致疫苗接种活动暂时停止。经过流行病学调查,卫生部得出结论,这些死亡与疫苗本身无关,接种活动得以恢复;然而,疫苗接种率显著下降。估计这一高危人群的实际背景死亡率将有助于开展公众教育,并平息对疫苗安全性的不必要担忧。我们使用来自一家大型健康维护组织(HMO)的数据,估算了连续四个冬季(2003年、2004年、2005年和2006年)55岁及以上流感疫苗接种者的死亡率。从患者治疗档案中确定免疫接种日期,通过以色列国家保险研究所的数据确定生命状态。我们计算了流感疫苗接种后7天、14天和30天内的粗死亡率,并使用Cox比例风险模型估算接种疫苗后14天内的死亡风险,对2006年的年龄和合并症(75岁以上、糖尿病或心血管疾病史、居家患者状态)进行了调整。流感疫苗接种者的死亡率在7天内为0.01%至0.02%,在30天内为0.09%至0.10%。在对合并症进行调整后,流感疫苗接种与14天内死亡风险降低相关(风险比,0.33,95%置信区间为0.18 - 0.61)。我们的研究结果支持这样的假设,即流感疫苗接种在短期内不会增加死亡风险。